Hologic Inc (HOLX)

Return on assets (ROA)

Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Net income (ttm) US$ in thousands 789,500 466,500 515,100 456,000 484,100 753,000 990,200 1,302,000 1,512,100 1,551,800 1,715,500 1,869,700 2,034,400 1,902,700 1,378,100 1,110,500 493,500 451,000 83,600 -203,600
Total assets US$ in thousands 9,156,000 8,714,400 8,469,500 9,139,300 9,337,900 9,448,700 9,290,300 9,071,200 9,357,400 9,514,500 9,285,100 8,919,900 8,590,600 8,044,000 7,550,700 7,195,800 6,803,100 6,821,800 6,311,900 6,442,100
ROA 8.62% 5.35% 6.08% 4.99% 5.18% 7.97% 10.66% 14.35% 16.16% 16.31% 18.48% 20.96% 23.68% 23.65% 18.25% 15.43% 7.25% 6.61% 1.32% -3.16%

September 30, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $789,500K ÷ $9,156,000K
= 8.62%

Hologic Inc's return on assets (ROA) has shown fluctuations over the past several quarters. The ROA was 8.62% as of September 30, 2024, which indicates that the company generated a net income of approximately 8.62 cents for every dollar of assets it possesses. This figure represents an improvement compared to the previous quarter's ROA of 5.35%.

Looking back over the last few quarters, the ROA has ranged from a low of -3.16% in September 2019 to a high of 23.68% in December 2021. The upward trend in the ROA in the recent quarters signals an increase in the company's efficiency in generating profits from its assets.

It is essential to consider the reasons behind these fluctuations in ROA, such as changes in the company's operational efficiency, profitability, and asset utilization. Investors and analysts may further examine the company's financial statements and performance metrics to assess the sustainability and competitiveness of Hologic Inc's ROA over the long term.


Peer comparison

Sep 30, 2024

Company name
Symbol
ROA
Hologic Inc
HOLX
8.62%
GE HealthCare Technologies Inc.
GEHC
4.83%